Otero Jose Manuel's Form 4 filing
Lexeo Therapeutics, Inc. (LXEO) · filed Nov 20, 2025
- Accession no.
- 0002024096-25-000005
- Filed
- Nov 20, 2025
- Trade date
- Aug 18, 2025
- Filing delay
- 94 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $6.68K. It was filed 94 days after the trade, past the 2-business-day deadline.
This filing was later replaced by the amendment 0002024096-26-000004 (Feb 20, 2026). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Otero Jose ManuelCIK 0002024096 | Officer (Chief Technical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2025 | Common Stock | SSaleDisposed | −721 | $9.27 | −$6,683.67 | 63,476 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.